PCSA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Processa Pharmaceuticals Inc (PCSA).


$2.89M Market Cap.

As of 03/20/2025 5:00 PM ET (MRY) • Disclaimer

PCSA Market Cap. (MRY)


PCSA Shares Outstanding (MRY)


PCSA Assets (MRY)


Total Assets

$3.23M

Total Liabilities

$1.53M

Total Investments

$0

PCSA Income (MRY)


Revenue

$0

Net Income

-$11.85M

Operating Expense

$12.05M

PCSA Cash Flow (MRY)


CF Operations

-$11.25M

CF Investing

-$3.24K

CF Financing

$7.73M

PCSA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

PCSA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$3,229,289 (-44.19%)

$5,786,643 (-32.87%)

$8,619,851 (-67.43%)

$26,463,505 (4.95%)

Assets Current

$1,873,619 (-66.74%)

$5,632,497 (-32.84%)

$8,386,729 (-54.24%)

$18,327,151 (13.11%)

Assets Non-Current

$1,355,670 (779.47%)

$154,146 (-33.88%)

$233,122 (-97.13%)

$8,136,354 (-9.71%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$8,056,638 (-8.93%)

Shareholders Equity

$1,696,171 (-66.00%)

$4,989,159 (-33.22%)

$7,470,741 (-70.69%)

$25,485,100 (11.10%)

Property Plant & Equipment Net

$75,693 (-49.07%)

$148,611 (-34.70%)

$227,587 (206.80%)

$74,181 (-53.36%)

Cash & Equivalents

$1,191,325 (-74.69%)

$4,706,197 (-27.64%)

$6,503,595 (-60.58%)

$16,497,581 (7.01%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$880,880 (75.95%)

$500,656 (-3.09%)

$516,599 (-16.77%)

$620,677 (-21.49%)

Accumulated Retained Earnings (Deficit)

-$87,219,199 (-15.72%)

-$75,369,081 (-17.31%)

-$64,247,561 (-74.48%)

-$36,823,332 (-45.00%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$70,274 (-8.76%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$73,507 (-51.18%)

$150,554 (-34.38%)

$229,450 (192.43%)

$78,463 (-76.09%)

Debt Current

$73,020 (-12.71%)

$83,649 (6.02%)

$78,896 (11.00%)

$71,078 (-65.29%)

Debt Non-Current

$487 (-99.27%)

$66,905 (-55.56%)

$150,554 (1938.65%)

$7,385 (-94.01%)

Total Liabilities

$1,533,118 (92.24%)

$797,484 (-30.60%)

$1,149,110 (17.45%)

$978,405 (-56.99%)

Liabilities Current

$1,532,631 (109.78%)

$730,579 (-26.84%)

$998,556 (2.84%)

$971,020 (-20.47%)

Liabilities Non-Current

$487 (-99.27%)

$66,905 (-55.56%)

$150,554 (1938.65%)

$7,385 (-99.30%)

PCSA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$4,782,060 (-15.47%)

$5,657,543 (-35.44%)

$8,763,058 (86.89%)

$4,688,939 (43.64%)

Research & Development Expense

$7,269,146 (25.34%)

$5,799,518 (-49.54%)

$11,494,230 (67.12%)

$6,878,021 (116.81%)

Operating Expenses

$12,051,206 (5.19%)

$11,457,061 (-58.38%)

$27,525,431 (126.85%)

$12,133,543 (-19.84%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

-$530,611 (46.99%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$11,850,118 (-6.55%)

-$11,121,520 (59.45%)

-$27,424,229 (-139.98%)

-$11,427,534 (20.72%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$11,850,118 (-6.55%)

-$11,121,520 (59.45%)

-$27,424,229 (-139.98%)

-$11,427,534 (20.72%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$11,850,118 (-6.55%)

-$11,121,520 (59.45%)

-$27,424,229 (-139.98%)

-$11,427,534 (20.72%)

Weighted Average Shares

$3,059,906 (133.30%)

$1,311,572 (-91.86%)

$16,109,291 (5.16%)

$15,319,463 (104.27%)

Weighted Average Shares Diluted

$3,059,906 (133.30%)

$1,311,572 (-91.86%)

$16,109,291 (5.16%)

$15,319,463 (104.27%)

Earning Before Interest & Taxes (EBIT)

-$11,850,118 (-6.55%)

-$11,121,520 (59.45%)

-$27,424,229 (-129.34%)

-$11,958,145 (20.98%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$12,051,206 (-5.19%)

-$11,457,061 (58.38%)

-$27,525,431 (-126.85%)

-$12,133,543 (19.84%)

PCSA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$3,244 (-16.86%)

-$2,776 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow from Financing

$7,733,414 (23.37%)

$6,268,724 (1712.15%)

-$388,843 (-103.97%)

$9,798,648 (-45.16%)

Net Cash Flow from Operations

-$11,245,042 (-39.46%)

-$8,063,346 (16.05%)

-$9,605,143 (-10.18%)

-$8,717,291 (-177.34%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,514,872 (-95.55%)

-$1,797,398 (82.02%)

-$9,993,986 (-1024.21%)

$1,081,357 (-92.66%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$3,244 (-16.86%)

-$2,776 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

-$5,202 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$7,754,518 (23.70%)

$6,268,724 (2189.57%)

-$300,000 (-102.99%)

$10,049,537 (-41.23%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$629,514 (-40.63%)

$1,060,339 (-87.99%)

$8,828,713 (159.06%)

$3,408,015 (24.83%)

Depreciation Amortization & Accretion

$87,966 (7.60%)

$81,752 (-90.65%)

$874,013 (-0.15%)

$875,349 (-0.76%)

PCSA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-233.20% (-64.92%)

-141.40% (12.28%)

-161.20% (-299.01%)

-40.40% (70.36%)

Return on Average Assets (ROAA)

-184.30% (-50.82%)

-122.20% (18.48%)

-149.90% (-293.44%)

-38.10% (63.78%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-2099.00% (24.90%)

-2795.10% (0.06%)

-2796.70% (-89.61%)

-1475.00% (-108.07%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.23 (71.10%)

-0.79 (-21.95%)

-0.65 (90.10%)

-6.53 (-151.66%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

1.7 (3.03%)

1.65 (-29.85%)

2.35 (-22.07%)

3.02 (-0.53%)

Debt to Equity Ratio (D/E)

0.9 (465.00%)

0.16 (3.90%)

0.15 (305.26%)

0.04 (-61.62%)

Earnings Per Share (EPS)

-3.87 (54.36%)

-8.48 (-398.82%)

-1.7 (-126.67%)

-0.75 (70.47%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-3.68 (40.23%)

-6.15 (-931.88%)

-0.6 (-4.75%)

-0.57 (-35.80%)

Book Value Per Share (BVPS)

0.55 (-85.44%)

3.8 (719.83%)

0.46 (-72.12%)

1.66 (-45.60%)

Tangible Assets Book Value Per Share (TABVPS)

1.05 (-76.09%)

4.41 (724.67%)

0.54 (-55.49%)

1.2 (-44.91%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

0 (0%)

-5 (0.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.01 (94.33%)

-0.14 (57.40%)

-0.33 (93.68%)

-5.24 (-4.87%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

1.22 (-84.15%)

7.71 (-8.20%)

8.4 (-55.50%)

18.87 (42.22%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$11,248,286 (-39.45%)

-$8,066,122 (16.02%)

-$9,605,143 (-10.18%)

-$8,717,291 (-177.34%)

Enterprise Value (EV)

$92,705 (-94.03%)

$1,552,540 (-82.32%)

$8,783,407 (-84.86%)

$58,016,734 (-18.45%)

Earnings Before Tax (EBT)

-$11,850,118 (-6.55%)

-$11,121,520 (59.45%)

-$27,424,229 (-129.34%)

-$11,958,145 (22.42%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$11,762,152 (-6.54%)

-$11,039,768 (58.42%)

-$26,550,216 (-139.56%)

-$11,082,796 (22.23%)

Invested Capital

$578,840 (15.67%)

$500,421 (-62.85%)

$1,347,150 (32.50%)

$1,016,729 (1646.69%)

Working Capital

$340,988 (-93.04%)

$4,901,918 (-33.65%)

$7,388,173 (-57.43%)

$17,356,131 (15.85%)

Tangible Asset Value

$3,229,289 (-44.19%)

$5,786,643 (-32.87%)

$8,619,851 (-53.17%)

$18,406,867 (12.46%)

Market Capitalization

$2,887,325 (-64.97%)

$8,241,691 (-53.15%)

$17,590,016 (-77.16%)

$77,008,380 (10.52%)

Average Equity

$5,080,996 (-35.40%)

$7,864,742 (-53.76%)

$17,007,375 (-39.94%)

$28,317,824 (167.82%)

Average Assets

$6,429,287 (-29.33%)

$9,098,059 (-50.27%)

$18,295,674 (-39.00%)

$29,991,230 (118.81%)

Invested Capital Average

$564,569 (41.89%)

$397,887 (-59.42%)

$980,579 (20.95%)

$810,707 (1078.63%)

Shares

3,266,944 (165.27%)

1,231,574 (-92.30%)

15,990,924 (1.75%)

15,715,996 (48.75%)